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Decline in estrogen levels promotes endothelial dysfunction and, consequently, the most
prevalent cardiovascular diseases in menopausal women. The use of natural therapies
such as pomegranate can change these results. Pomegranate [Punica granatum
L. (Punicaceae)] is widely used as a phytotherapeutic agent worldwide, including
in Brazil. We hypothesized that treatment with pomegranate hydroalcoholic extract
(PHE) would improve coronary vascular reactivity and cardiovascular parameters. At
the beginning of treatment, spontaneously hypertensive female rats were divided into
Sham and ovariectomized (OVX) groups, which received pomegranate extract (PHE)
(250 mg/kg) or filtered water (V) for 30 days by gavage. Systolic blood pressure
was measured by tail plethysmography. After euthanasia, the heart was removed
and coronary vascular reactivity was assessed by Langendorff retrograde perfusion
technique. A dose-response curve for bradykinin was performed, followed by L-NAME
inhibition. The protein expression of p-eNOS Ser1177, p-eNOS Thr495, total eNOS,
p-AKT Ser473, total AKT, SOD-2, and catalase was quantified by Western blotting. The
detection of coronary superoxide was performed using the protocol of dihydroethidium
(DHE) staining Plasma nitrite measurement was analyzed by Griess method. Systolic
blood pressure increased in both Sham-V and OVX-V groups, whereas it was reduced
after treatment in Sham-PHE and OVX-PHE groups. The baseline coronary perfusion
pressure was reduced in the Sham-PHE group. The relaxation was significantly higher
in the treated group, and L-NAME attenuated the relaxation in all groups. The treatment
has not changed p-eNOS (Ser1177), total eNOS, p-AKT (Ser473) and total AKT in any
groups. However, in Sham and OVX group the treatment reduced the p-eNOS (Thr495)
and SOD-2. The ovariectomy promoted an increasing in the superoxide anion levels and
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the treatment was able to prevent this elevation and reducing oxidative stress. Moreover,
the treatment prevented the decreasing in plasmatic nitrite. We observed a reduction
in total cholesterol and LDL in the Sham-PHE group. The treatment with PHE
enhances the endothelium-dependent coronary relaxation and improves cardiovascular
parameters, which suggests a therapeutic role of PHE.
Keywords: hypertension, pomegranate extract, phytoestrogens, antioxidant effects, vasodilation, coronary
arteries
INTRODUCTION
Cardiovascular diseases (CVDs) are the main cause of death
in many nations. Characteristics such as age, sex and genetic
predisposition can be highlighted among the “non-modifiable”
risk factors; whereas diet and lifestyle are considered “modifiable”
(Leifert and Abeywardena, 2008; Mozaffarian et al., 2016).
Hypertension has been recognized as a major risk
factor for CVDs (Pickering, 1972). However, studies
have shown that premenopausal women have less risk of
development hypertension and other CVDs when compared to
postmenopausal women, suggesting vascular protective effects of
female sex hormones (Farhat et al., 1996). The beneficial vascular
effects of estrogen have been ascribed to a variety of factors,
including endothelium-dependent and independent vascular
relaxation (Gisclard et al., 1988). Furthermore, estrogen can
reduce the oxidative stress, an effect that might be attributed to its
capacity to decrease reactive oxygen species (ROS). However, the
role of sex hormones (mainly estrogen) on the enzymes involved
in the intracellular signaling, i.e., kinases, is very controversial.
Indeed, while some authors demonstrated that estrogen could
modulates kinases proteins expression such as Akt (Bhuiyan
et al., 2011; Turdi et al., 2015), PKG (Word and Cornwell, 1998)
and PKC (Hunter and Korzick, 2005; Hunter et al., 2007), others
suggest that there is no modulation by estrogen on these kinases
(Teede et al., 2001; Cao et al., 2015; Leung et al., 2015). Taken
together, these studies showed that the relationship between
the expression of kinases and estrogen levels is very complex
which becomes a limiting factor for the use of estrogen therapy
in postmenopausal women. In addition, the risk of uterine
and breast cancer is another factor that restricts the use of
estrogen therapy (Santos et al., 2014). Thus, new substances
that could offer similar benefits as estrogen can be used as an
alternative treatment in CVDs prevention (Borrás et al., 2010).
Among them, pomegranate that has a high concentration of
phytoestrogens has been used as hormonal therapy to reduce
the postmenopausal symptoms (Glazier and Bowman, 2001;
Auerbach et al., 2012). Even though some studies have shown
beneficial effects of pomegranate, further research is needed.
The phytoestrogens are exogenous agents that have the ability
to mimic endogenous hormones and these compounds are
present in a wide variety of plants (Larrosa et al., 2006). The
phytoestrogens have attracted attention due to its ability to act on
the estrogen receptor (ER) subtype ERα, ERβ (Zhai et al., 2001;
Papoutsi et al., 2005) and G protein-coupled oestrogen receptor
Abbreviations: OVX, ovariectomized rats; PHE, pomegranate hydroalcoholic
extract.
(GPER) (Dong et al., 2013). Phytoestrogens may have beneficial
effects on the cardiovascular system and also for osteoporosis and
breast cancer (Lissin and Cooke, 2000).
Punica granatum L. (Punicaceae) is the fruit with the
highest phytoestrogen concentrations, which contains significant
amounts of phenolic antioxidants (Espín et al., 2007). This
fruit is a native shrub of occidental Asia and Mediterranean
Europe, popularly referred as pomegranate (Vidal et al., 2003).
For centuries this plant has been used to ameliorate several
diseases (Gracious Ross et al., 2001). Ancient Egyptian culture
regarded the pomegranate fruit as a symbol of ambition and
prosperity, making it common practice to decorate sarcophagi
with this plant. According to ancients Ebers’ papyrus (1500 BC),
the plant was used by Egyptians as a treatment for tapeworm and
other parasitic infestations. The pomegranate, that was lauded in
ancient times in the Old Testament of the Bible, the Jewish Torah,
and the Babylonian Talmud is also known as a sacred fruit that
conferring powers of fertility (Jurenka, 2008). In recent decades,
pomegranate has been studied for many potential uses including:
immunomodulation, atherosclerosis/arteriosclerosis, bacterial
infection, fungal infection, parasitic infection, periodontal
disease, and food poisoning (Gracious Ross et al., 2001; Prashanth
et al., 2001; Schubert et al., 2002; Longtin, 2003). Currently,
Sreeja et al. (2012) indicate that the pomegranate has a potential
application as a possible alternative to hormone replacement
therapy.
There has been great interest in pomegranate as a medicinal
and nutritional product mainly due to its high polyphenol
content, which contributes to a strong antioxidant effect, making
it a useful tool against damage caused by hypertension (Mohan
et al., 2010). Nevertheless, the effects of pomegranate on vascular
reactivity of coronary bed have not been fully elucidated.
Thus, we hypothesized that treatment with PHE enhances
the endothelium-dependent coronary relaxation and improves
cardiovascular parameters in ovariectomized spontaneously
hypertensive female rats (SHR) by reducing oxidative stress.
Therefore, the main purpose of this study was to determine
the effect of chronic treatment with PHE on the coronary
endothelium-dependent vasodilator response.
MATERIALS AND METHODS
Experimental Animals
In this study, 4-weeks-old females SHR (150± 10 g body weight)
were obtained at the animal facility in the Centre of Health
Sciences at Federal University of Espirito Santo. This study
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was carried out in strict accordance with the recommendations
in the Brazilian Guidelines for the Care and Use of Animals
for the Scientific Purpose and Didactics and the Guidelines
Euthanasia Practice (CONCEA-MCT, 2013). All procedures were
approved by the Committee on the Ethics of Animal Care
and Use of the Federal University of Espirito Santo under
protocol No. 054/2012. The animals were housed in collective
cages (five animals per cage) and were provided food (Purina
Labina) and water ad libitum. Also, they were maintained under
controlled conditions of temperature (22–24◦C) and humidity
(40–60%), with a 12/12 h light-dark cycle. The animals were
randomly divided into four groups: Sham Vehicle (Sham-V),
Sham Pomegranate hydroalcoholic extract (Sham-PHE), OVX
Vehicle (OVX-V), and OVX Pomegranate hydroalcoholic extract
(OVX-PHE).
Ovariectomy
The ovariectomy was performed under general anesthesia with
ketamine (80 mg/kg) and xylazine (12 mg/kg) i.p. The bilateral
dorsolateral incision was made through the skin and underlying
muscle was dissected to locate the ovary and uterine tube. The
tube was ligated with a suture line and the ovaries were removed.
The muscle and skin were then sutured with an absorbable suture.
After the surgery animals received an injection of antibiotic (2,5%
enrofloxacin, 0,1 mL, i.m). In Sham animals, it was made a
fictitious surgical procedure (Claudio et al., 2013).
Preparation of Pomegranate Peel Extract
The plant material of choice (P. granatum L.) belongs to the
family Lythraceae. The plant samples were authenticated by Dra.
Valquíria Ferreira Dutra at the Department of Biological Sciences,
Federal University of Espirito Santo, where a sample (voucher
specimen number 37631) was deposited in the herbarium of
the VIES/UFES in botany sector. Extract preparation protocol
was modified from that described by Lapornik et al. (2005). The
pomegranate was collected for extraction purposes, the peel was
removed and dried for 5 days and then grounded. The material
(85,71 g) was mixed in 1000 mL of ethanol (95 GL) in an
amber bottle until the complete extraction of peel compounds.
Afterward, the sample was vacuum filtrated, the supernatant was
collected, the alcohol was evaporated in a rotary evaporator at
60◦C. The crude extract (68%, w/w) was kept in a 4◦C in an amber
bottle.
Phytochemical Analysis
Extracts were tested for the presence of active principles such as
triterpenoids, steroids, glycosides, saponins, alkaloids, flavonoids,
tannins, proteins, free amino acids, carbohydrate, and organic
acid. Standard procedures were used (Bhandary et al., 2012).
Treatment of Pomegranate Peel Extract
The PHE was diluted in filtered water and administered for
30 days orally by gavage (250 mg/kg). The control groups received
filtered water as vehicle. The treatment started after 3 days of
post-surgical and at the end of the treatment, the animals were
8-weeks-old.
Non-invasive Assessment of Blood
Pressure
After a period of adaptation, the animals were placed in a heated
chamber within a container and restrained with a pneumatic cuff
attached to the proximal region of the tail. A sphygmomanometer
was inflated and deflated automatically, and the systolic blood
pressure (SBP) was recorded using a transducer coupled to
a computer, as previously described (Baldo et al., 2011). The
temperature was maintained at 29 and 32◦C for 40 min, during
which the animals remained in the chamber (IITC INC/Life
Science, 23924 Victory Blvd, Woodland Hills, CA 91367-1253,
USA). Averages of three measurements were obtained, with a
maximum difference of 10 mmHg, and measurements associated
with animal movements were discarded. The non-invasive
measurement was done 1 day before the treatment had started
and on the last day of the treatment (30th).
Studies in Isolated Hearts
At the end of treatment, the animals were anesthetized with
ketamine (80 mg/kg) and xylazine (12 mg/kg) i.p and euthanized
via decapitation for blood collection. The heart was excised
and immediately transferred to the perfusion apparatus and
isolated through cannulation of the aorta. The studies on
the coronary vascular bed were performed on whole hearts
using a modified Langendorff preparation for perfused isolated
hearts as previously described (Santos et al., 2004). Briefly,
using a Langendorff apparatus (Hugo Sachs Electronics, March-
Hugstetten, Germany), the isolated hearts were perfused with
modified Krebs solution containing 120 mM NaCl, 1.25 mM
CaCl2.2H2O, 5.4 mM KCl, 2.5 mM MgSO4.7H2O, 2.0 mM
NaH2PO4.H2O, 27.0 mM NaHCO3, 1.2 mM Na2SO4, 0.03 mM
EDTA, and 11.0 mM glucose, heated continuously at 37◦C in a
water bath and equilibrated with a 95% oxygen and 5% carbon
dioxide mixture at a controlled pressure of 100 mmHg to give a
pH of 7.4. Coronary flow was maintained constant at 10 mL/min
using a roller pump (Hugo Sachs, Germany).
The baseline coronary perfusion pressure (CPP) was
measured using a pressure transducer (AD Instruments
MLT0380/A Reusable BP Transducer) connected in proximity
to the aortic perfusion cannula through which the coronary
artery bed was perfused and connected to a digital data
acquisition system (PowerLab System). The obtained data were
analyzed using LabChart 7.3.1 software (Copyright© 1994-2011
ADInstruments). Because the flow rate was maintained constant
at 10 mL/min with a roller pump, the changes in CPP were
directly related to changes in vascular resistance. A latex balloon
at the end of a steel cannula was inserted into the left ventricle
and connected to a pressure transducer (AD Instruments
MLT0380/A Reusable BP Transducer) for measurement of the
isovolumetric cardiac force. The balloon was pressurized with
the aid of a glass syringe to maintain a preload of 10 mmHg.
After stabilization of the system for 40 min, baseline CPP
was calculated, and the endothelium-dependent vasodilation was
analyzed in coronary arterial bed, randomly, through in bolus
administration (0.1 mL) of bradykinin (Sigma, St. Louis, MO,
USA) in concentrations of 0.1, 1, 10, 100, and 1000 ng, followed
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by 100 µM of Nω-nitro-L-arginine ethyl ester (L-NAME; non-
specific inhibitor of nitric oxide synthase – NOS). The relaxing
response was expressed as percentage of relaxation and calculated
by the following equation for each dose:
1% =
(
CPPafter infusion × 100
CPPbefore infusion
)
− 100
Isolation of Coronary Arteries
At the end of treatment, the animals were anesthetized with
ketamine (80 mg/kg) and xylazine (12 mg/kg) i.p and euthanized
via decapitation for blood collection. The thorax cavity was
opened, and the heart was removed and placed in cold Krebs-
Henseleit solution buffer (in mmol/L): 115 NaCl, 25 NaHCO3,
4,7 KCl, 1,2 MgSO4.7H2O, 2,5 CaCl2, 1,2 KH2PO4, 5,5 glucose
and 0,01 Na2EDTA at pH 7.4 during the dissection procedure.
The left anterior descending branch of the left coronary artery
and the septal branch were isolated in a dissection microscope
(D.F. Vasconcelos M900, São Paulo, Brazil), free of surrounding
ventricular muscle tissue and snap frozen in liquid nitrogen.
Afterward, the samples were stored at −80◦C until their use
(Claudio et al., 2013).
Western Blotting
The hearts were collected, septal coronary arteries dissecated,
then, the arteries were quickly frozen and stored until
be processed for Western Blot analysis. Each sample was
homogenized in modified RIPA buffer (in mmol/L): Tris-HCl
65.2; NaCl 154; NP-40 1% sodium deoxycolate 0.25%; EDTA
0.8; PMSF 1; Sodium orthovanadate 10; Sodium fluoride 100;
Sodium Pyrophosphate 10 and protease inhibitor to prevent
proteolysis and maintain the protein phosphorylation. Tissue
homogenates were centrifuged at 10,000 rpm and 4◦C for 10 min
to remove tissue debris. Protein concentration in the samples
was determined by Bradford method (Quick Start Bradford, Bio-
Rad). Protein from the tissue samples (10 µg) was separated on
8% SDS-PAGE and transferred to a nitrocellulose membrane.
Membranes were blocked for 120 min with 5% non-fat milk in
Tris-buffered solution at room temperature. Membranes were
incubated with rabbit primary antibody against p-eNOS Ser1177
(1:1,000, Cell Signaling, cat 95715, lot #14, USA), mouse primary
antibody against p-eNOS Thr495 (1:1,000, BD, cat 612707,
lot #2146880, USA), mouse primary antibody against NOS-
3.(1:2,000, BD, cat 610296, lot #4077705, USA), rabbit primary
antibody against p-AKT Ser473 (1:2,000, Cell Signaling, cat 4060,
lot #19, USA), rabbit primary antibody against AKT (1:1,000, Cell
Signaling, cat 4685, lot #3, USA), mouse monoclonal anti-catalase
antibody (1:2000; Sigma, cat. C0979, lot. #082M4837, USA)
and a rabbit polyclonal anti-SOD-2 antibody (1:500; Sigma, cat.
SAB2102261, lot #QC25874, USA overnight, at 4◦C. Afterward,
membranes were incubated with a HRP-conjugated goat anti-
rabbit (1:10,000, Cell Signaling, cat 7074, lot #24, USA) or horse
anti-mouse (1:10,000 Cell Signaling, cat 7076, lot #27, USA)
secondary antibody for 60 min at room temperature. Protein
bands were identified by means of chemiluminescence (ECL, GE
Healthcare) and measured by densitometry.
Detection of Superoxide Production
The protocol of Dihydroethidium (DHE) staining was performed
according to Dos Santos et al. (2016). Briefly, unfixed frozen
coronary sections (8 µm) were incubated with 2 µmol DHE
(Molecular Probes, Sigma, D7008) in modified Krebs solution
containing 20 mmol Krebs-HEPES for 30 min in a light-protected
chamber at 37◦C. Subsequently, the samples were subjected
to wash with phosphate-buffered saline (PBS), and mounted
with neutral glycerine. The levels of ROS were determined
using microscopy, and coronary fluorescence was quantified with
microscope software (Image Pro Plus 4.0). The red fluorescence
intensity of the coronaries was quantified in 10 arbitrarily selected
coronaries, and the mean value for each islet was calculated.
Nitrite Measurement in the Plasma
Nitrite (NO−2 ) concentration was evaluated using the Griess
method as described previously with modifications (Silva et al.,
2011). Briefly, in a 96 wells plate were added a sample (100 µL)
of rat plasma and 100 µL Griess reagent freshly prepared
[1% sulfanilamide, 0.1% N-(1-naphthyl) ethylenediamine and
2.5% phosphoric acid]. After homogenization, the mixture was
incubated for 10 min, at room temperature. The absorbance
was measured at 548 nm by spectrophotometry (Epoch
Microplate Spectrophotometer, Biotek R© , VT, USA) and total
nitrite concentrations were calculated using a standard curve
build with known concentrations of nitrite. The water was
considerate as blank solution.
Serological Dosages
For determination of the lipid profiles, the blood was centrifuged
(Centrifuge Excelsa R© IV Model 280R) at 3500 rpm for 15 min
at 4◦C, and the serum was collected and stored at −20◦C. The
concentrations of total cholesterol (TC), triglycerides (TG), and
high-density lipoprotein (HDL) cholesterol were measured using
the enzymatic methods of the Colestat enzyme kit AA, TG Color
GPO/PAP AA kit, and HDL cholesterol monophase AA Plus kit,
respectively, with a Konelab model 600i spectrophotometer. The
concentrations of low-density lipoprotein (LDL) cholesterol and
very-low-density lipoprotein (VLDL) cholesterol were calculated
using the Friedewald equation (Friedewald et al., 1972): VLDL
cholesterol = triglycerides/5, and LDL cholesterol = total
cholesterol – (HDL+ VLDL).
Statistical Analysis
All data are expressed as the mean ± SEM. To identify possible
outlier data, a two-sided Grubbs’ test was used to identify whether
at least one outlier was present in each data set. When the
Grubbs’ test identified one outlier, we used an adapted ROUT
method to detect any outliers from that column data and
removed them according to the Q setting at 1% (alpha = 0.01).
For each data set, D’Agostino-Pearson omnibus normality test
was also performed. If the data passed the normality test, then
comparisons among groups were performed through one-way
analysis of variance (one-way ANOVA) followed by Tukey’s
post hoc test, considering the treatment as the main factor.
The vasodilator response to bradykinin was evaluated through
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two-way analysis of variance (two-way ANOVA) followed by
Bonferroni’s post hoc test and a significance level of P < 0.05 was
established.
RESULTS
Qualitative Phytochemical Analysis
A qualitative phytochemical analysis was made and the results
showed the presence of triterpenoids, glycosides, saponins,
flavonoids, tannins, carbohydrates, and organic acid in the PHE
(Table 1).
TABLE 1 | Qualitative phytochemical test of the pomegranate peel
hydroalcoholic extract.
Test Bhandary et al., 2012 PHE
(I) Test for triterpenes and
steroids
Liebermann Burchard test − DN
Test with chloroform, acetic
anhydride and H2SO4
DN +
(II) Test for glycosides
Keller Killiani test − DN
Bromine water test − DN
Test with Sodium nitroprusside 5% DN +
Baljet reactive DN +
(III) Test for Saponins
Foam test − +
(IV) Test for Alkaloids
Hager’s Test − DN
Bouchardat reactive DN −
Dragendorff reactive DN −
(V) Test for Flavonoids/Phenols
FeCl3 test + +
Test with alkaline reagent + + (Flavonoids)
Test with acid reagent DN −
Test with acetate solution + DN
(VI) Test for Tannins
Gelatin test + DN
Test with FeCl3 DN +
(VII) Test for protein
Biureto test − −
Spectroscopy DN −
(VIII) Test for free amino acids
Test with ninhydrine − −
(IX) Test for Carbohydrates
Benedict test + DN
Test with lugol DN −
Reducing sugars (Fehling reactive) DN +
Sugar. not Reducers/heterosides
(Fehling reactive)
DN +
(X) Test for Vitamin C
DNPH test − DN
(XI) Test for Organic acids
Pascová reactive DN +
DN, did not; +, present;−, not present.
Effects of PHE on Systolic Blood
Pressure
The SBP data are summarized in Figures 1A,B. As expected,
30 days after the beginning of the study, we observed that the SBP
increased in Sham-V group (165± 4 to 180± 3 mmHg, P< 0.05)
as well as in OVX-V (155 ± 4 to 173 ± 3 mmHg, P < 0.05). In
addition, we found that the treatment with PHE decreases SBP in
Sham-PHE group (150± 3 mmHg, P < 0.05). In the other hand,
the treatment was able to prevent the progression of hypertension
in OVX-PHE (150± 1.5 mmHg, P< 0.05) group when compared
to the beginning of the treatment.
Coronary Vascular Reactivity
As showed in Figure 2, we observed that the treatment with
PHE significantly reduced the basal CPP in the Sham group
(Sham-V: 137 ± 6 mmHg vs. Sham-PHE: 110 ± 5 mmHg,
FIGURE 1 | Systolic blood pressure (SBP) at the beginning (0 day) and
end of treatment (30 days). Vehicle (V) and Pomegranate hydroalcoholic
extract (PHE) in Sham group (A) and Ovariectomized group (OVX) (B). Values
are expressed as mean ± SEM; n = 10–16 animals per group. ∗p < 0.05
compared to 0 Day values, #p < 0.05 compared to the Vehicle group.
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FIGURE 2 | Baseline coronary perfusion pressure (CPP) after the
treatment. Sham treated with Vehicle (Sham-V), Sham treated with
Pomegranate hydroalcoholic extract (Sham-PHE), Ovariectomized treated
with Vehicle (OVX-V) and Ovariectomized treated with Pomegranate
hydroalcoholic extract (OVX-PHE) groups. Values are expressed as
mean ± SEM; n = 9–12 animals per group. ∗∗p < 0.01 compared to the
Sham-V group.
FIGURE 3 | Dose-response curves to bradykinin (0,1–1000 ng) in
isolated hearts. Sham group (A) and OVX group (B) before (closed symbols)
and after (open symbols) perfusion with L-NAME (100 µM) for 20 min. Data
were expressed as mean ± SEM; n = 6–10 animals per group. ∗p < 0.05
compared with the vehicle group before L-NAME. #p < 0.05 compared with
the both groups after L-NAME.
P < 0.01). In Figure 3, we analyzed the functionality of the
endothelium through the curve dose-response to bradykinin and
observed that the vasodilator response was present in both the
Sham (Figure 3A) and OVX (Figure 3B) groups. The treatment
significantly increased vasodilator response when compared to
their respective control groups (P < 0.05). After inhibition with
L-NAME, we observed an attenuation of the vasodilator response
in all groups (P < 0.05).
Analysis of Protein Expression (Western
Blotting)
We found that the treatment was able to decrease the p-eNOS
(Thr495) in Sham (Sham-V: 0.23 ± 0.01 vs. Sham-PHE:
0.12 ± 0.02, P < 0.05) and OVX groups (OVX-V: 0.19 ± 0.03
vs. OVX-PHE: 0.12 ± 0.03, P < 0.05) (Figure 4B). However,
FIGURE 4 | Analysis of protein expression in Sham and OVX rats. (A)
p-eNOS (Ser1177), (B) p-NOS (Thr495) and (C) total eNOS in Sham-V,
Sham-PHE, OVX-V and OVX-PHE. Each sample was obtained from 1 vessel
from coronary septal arteries, and the analyses of different proteins were
made in the same gels using isolated strip buffer. However, the organization of
the groups not allowed us to remove a representative image of the blots in a
single gel. Thus, for better clarification we reorganized the blots separately.
Data were expressed as mean ± SEM; n = 5–10 per group. ∗p < 0.05
compared to Sham-V group.
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FIGURE 5 | Analysis of protein expression in Sham and OVX rats. (A)
p-AKT (Ser 473), (B) total AKT in Sham-V, Sham-PHE, OVX-V, and OVX-PHE.
Each sample was obtained from 1 vessel from coronary septal arteries, and
the analyses of different proteins were made in the same gels using isolated
strip buffer. However, the organization of the groups not allowed us to remove
a representative image of the blots in a single gel. Thus, for better clarification
we reorganized the blots separately. Data were expressed as mean ± SEM;
n = 5–10 per group.
we did not observe significant differences in the p-eNOS
Ser1177 (Figure 4A), total eNOS (Figure 4C), p-AKT Ser473
(Figure 5A) and total AKT (Figure 5B). In addition, the
PHE was effective to prevent the decreasing in expression
of enzymes SOD-2 (Figure 6A) in the OVX group (OVX-
V: 0.82 ± 0.1 vs. OVX-PHE: 1.31 ± 0.1, P < 0.05)
and not changed the catalase expression in any group
(Figure 6B).
Analysis of the Superoxide Anion
The DHE oxidative assay revealed intense fluorescence in
OVX-V group when compared both Sham-V and OVX-PHE
animals. Interestingly, the antioxidant effect of the treatment
was observed in the OVX-PHE coronary arteries group, as
represented in Figure 7. (Sham-V: 0.57 ± 0.05 vs. Sham-PHE:
0.64 ± 0.01 vs. OVX-V: 0.96 ± 0.04 vs. OVX-PHE: 0.76 ± 0.03,
P < 0.01).
FIGURE 6 | Analysis of protein expression in Sham and OVX rats. (A)
superoxide dismutase, SOD-2 and (B) catalase in Sham-V, Sham-PHE,
OVX-V, and OVX-PHE. Data were expressed as mean ± SEM; n = 4–7 per
group. #p < 0.05 compared with OVX-V group.
Analysis of Plasma Nitrite Levels
The treatment did not increase the plasma nitrite formation
in Sham-PHE group (Sham-V: 0.448 ± 0.04 µM and Sham-
PHE: 0.454 ± 0.06 µM) (Figure 8). On the other hand,
the hormonal dysfunction induced by castration reduced the
formation of plasma nitrite (Sham-V: 0.448± 0.04 µM vs. OVX-
V: 0.212 ± 0.04 µM, P < 0.05). The treatment in OVX group, in
turn, was able to prevent the reduction in plasma nitrite levels
(OVX-V: 0.212 ± 0.04 µM vs. OVX-PHE: 0.515 ± 0.07 µM,
P < 0.05).
Analysis of Lipid Profile
We observed a significant reduction in the levels of total
cholesterol and LDL (Table 2) in the Sham-PHE group compared
to the Sham-V group. In the OVX-PHE group, the treatment
significantly reduced the levels of LDL and triglycerides when
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FIGURE 7 | Influence of pomegranate peel extract treatment on superoxide anion production in coronary arteries. The top panels (A–D) show higher
fluorescence intensity (red) in OVX-V rats when compared both Sham and OVX-PHE rats using dihydroethidium (DHE) staining. Left panel, vehicle treatment and
right panel, pomegranate hydroalcoholic extract treatment (PHE). (E) The bar graph shows the average DHE fluorescence (AU: arbitrary units) comparing all groups
(n = 9–12). Values are means ± SEM. ∗∗p < 0.01 compared with Sham, and ##p < 0.01 compared with OVX-PHE group. Scale bar: 50 µm.
compared to the OVX-V. HDL concentration was not altered in
any of the studied groups.
DISCUSSION
The main finding of the present study is that the treatment
with PHE was able to improve the endothelium-dependent
coronary relaxation and these effects can be related to
inhibition of eNOS phosphorylation at its inhibitory residue
Thr495 and reduce oxidative stress. In addition, the treatment
was effective in attenuating the SBP and in preventing its
progression.
As expected, 30 days after the beginning of the study we
observed that the SBP increased in both groups (Sham-V and
OVX-V). This result has been showed by other studies (Okamoto
and Aoki, 1963; Imada et al., 1985; Androwiki et al., 2015).
Moreover, we found that the treatment with PHE decreased SBP
in Sham-PHE group. In addition, even that the treatment was not
able to reduce the SBP in OVX-PHE group when compared to
the onset of the treatment, we could observe that it prevented
the progression of hypertension. A possible explanation for
our findings is related to the fact that PHE can act as a
therapeutic agent in hypertension due to its potent antioxidant
activity, via polyphenols. These polyphenols are capable of
protecting nitric oxide (NO) against superoxide anion (O•−2 ) –
mediated oxidation, thus increasing its biological actions, such
as endothelium-dependent relaxation (Ignarro et al., 2006).
There is a relationship between hypertension and impaired
endothelial function, leading a decrease in NO bioavailability,
which characterizes the endothelial dysfunction (Hamilton et al.,
2001). In hypertension occurs an increase in O•−2 generation
leading to a lower NO bioavailability. O•−2 rapidly reacts with NO,
forming peroxynitrite and decreasing NO bioavailability (Rey
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FIGURE 8 | Analysis of plasma nitrite levels. Values in Sham-V,
Sham-PHE, OVX-V and OVX-PHE. Data were expressed as mean ± SEM;
n = 6–12 animals per group. ∗p < 0.05 compared to the Sham-V group.
#p < 0.05 compared with OVX-V group.
et al., 2001; Androwiki et al., 2015). Additionally, sex hormonal
deficiency enhances the progression of endothelial dysfunction
and studies have indicated that the cardiovascular protection
observed in premenopausal females has been attributed to the
beneficial effects of estrogen on endothelial function (Reckelhoff,
2001). estrogen can act on releasing of endothelium-derived
vasodilator factors and also inhibit the renin–angiotensin system
(Reckelhoff et al., 2000; Santos et al., 2010).
Pomegranate has a high antioxidant capacity due to raised
polyphenols concentrations, more specifically hydrolysable
tannins, which are capable of scavenging free radical (Aviram
and Rosenblat, 2012). Besides its scavenger effect, we have
previously shown that pomegranate is able to reduce the
angiotensin-converting enzyme (ACE) activity (Santos et al.,
2016) contributing to an environment with less oxidative stress
consequently reducing CVDs risk (Aviram and Dornfeld, 2001;
Mohan et al., 2010). In addition, with the ACE inhibition there
is a decreasing in bradykinin degradation that may contribute to
our results (Shiuchi et al., 2002).
We observed that the treatment was effective in reducing
the baseline CPP only in the Sham-PHE group. Hormonal
dysfunction in OVX females is an important factor to the
TABLE 2 | Analysis of lipid profile in Sham and ovariectomized (OVX) rats
(n = 7–13 animals per group).
Groups TC TG HDL LDL
(mg/dL) (mg/dL) (mg/dL) (mg/dL)
Sham-V 54 ± 5.4 54 ± 5.6 15.6 ± 0.6 21 ± 1.5
Sham-PHE 39 ± 2.9∗∗ 74 ± 6.8 15.8 ± 0.7 14 ± 0.6∗
OVX-V 54 ± 1.4 65 ± 4.5 15.7 ± 0.7 24 ± 1.7
OVX-PHE 48 ± 1.6 37 ± 3.1# 16.3 ± 0.5 18 ± 1.5#
Data were expressed as ±SEM. ∗p < 0.05, ∗∗p < 0.01 compared to Sham-V
group. #p < 0.05 compared to OVX-V group.
TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein and LDL, low-
density lipoprotein.
development of hypertension and coronary artery disease
because the presence of estrogen is able to modulate the NO
synthesis by acting on the isoforms of the enzyme nitric oxide
synthase (NOS). Indeed, results from our laboratory indicate
that the main endothelial mediator responsible for regulating
the coronary vascular tone (represented by the baseline CPP)
is the NO in both Wistar and SHR rats (Santos et al., 2004,
2010, 2016). Therefore, ovariectomy leads to damages on the
endothelial function, as previously showed by our study group
(Borgo et al., 2011; Caliman et al., 2013; Claudio et al., 2013;
Oliveira et al., 2014; Lamas et al., 2015); impairing thus, the
preventive/therapeutic effects from the PHE on the baseline CPP
values in the OVX-PHE group. Another suggestion is that the
beneficial effects from the treatment are probably dependent
on circulating estrogen levels in the blood, since we observed
that animals with normal estrogen levels (Sham) showed the
benefits generated by the treatment. In view of this hypothesis,
we suggest that the castration may have caused a reduction in the
beneficial effects of estrogen, perhaps by reduction of its receptors
in coronary arteries of the hypertensive rats, as previously showed
(Borgo et al., 2016).
Such antioxidant characteristics of polyphenols confer
protective effects on the blood vessels due to a reduction of
oxidative stress in endothelial cells, improving the vascular
reactivity. Thus, our results are in agreement with literature data,
since the endothelium-dependent relaxation was enhanced in
all treated groups (Machha and Mustafa, 2005; Ajay et al., 2007;
Yilmaz and Usta, 2013). Nevertheless, L-NAME impaired the
endothelium-dependent relaxation, which shows that there is a
strong participation of NO in this response. To our knowledge,
we are the first ones to demonstrate the PHE treatment modulates
vascular reactivity of the coronary bed. Our data corroborate the
study of Machha and Mustafa (2005), which showed that chronic
treatment with flavonoids improves endothelium-dependent
relaxation, reduces SBP and significantly improves endothelial
function in hypertensive animals. The PHE acts as exogenous
antioxidant system neutralizing ROS and increases the NO
bioavailability. It is known that the antioxidant system is any
substance that, when present at low concentration compared
with those of any oxidizable substrate, significantly delays or
prevents oxidation of that substrate (Halliwell and Gutteridge,
2007).
Addition to the elevated concentrations of polyphenols
with high antioxidant capacity, the pomegranate has a
high concentration of phytoestrogens which can confer
cardioprotective effects similar to estrogen. Among the
phytoestrogens that are known, urolithins A and B
(enterophytoestrogens), which are microflora metabolites
from the ellagic acid that belongs to the tannins class, display
both oestrogenic and antioestrogenic activities (Larrosa et al.,
2006; Ryu et al., 2016). It is know that estrogen phosphorylate
eNOS mainly via the serina (Ser)/threonine (Thr) kinase
Akt (Förstermann and Sessa, 2012). In fact, the treatment
promotes its beneficial effects through the inhibition of eNOS
phosphorylation at its inhibitory residue Thr495. However, we not
observed alterations after the treatment in total eNOS and total
AKT as well as in their phosphorylated form in residue Ser1177.
Frontiers in Pharmacology | www.frontiersin.org 9 January 2017 | Volume 7 | Article 522
fphar-07-00522 December 27, 2016 Time: 17:33 # 10
Delgado et al. Pomegranate Enhances Coronary Relaxation
Another Therefore, the PHE effect that may have contributed to
improved endothelium-dependent relaxation may be related to
its antioxidant properties described in the literature (Gil et al.,
2000) and its scavenging capacity (Sun et al., 2016). It was
postulated that treatment with PHE might decrease oxidative
stress in animals with hypertension (Dos Santos et al., 2016). It
is know that the oxidative stress is related to an increased ROS
generation. Such increase overloads the antioxidant system to
neutralize these substances, which can induce the development
and/or progression of chronic degenerative diseases such as
hypertension and coronary heart disease (Beswick et al., 2001;
Shah and Channon, 2004; Androwiki et al., 2015).
In view of this, we decided to analyze the ability of
treatment in reducing oxidative stress by the DHE oxidative
assay. We observed an intense fluorescence in OVX-V group
when compared with both Sham-V and OVX-PHE animals. In
addition, the treatment was able to reduces the O•−2 production.
These results support the notion that one of the mechanisms
involved in attenuation of damage derived from hypertension
may be related to the reduction of oxidative stress and increasing
of the NO bioavailability as demonstrated in this study. This
result corroborates a previous study of from our laboratory (Dos
Santos et al., 2016). Thus, the cardioprotective effects from PHE
observed in this study can be in part derived from antioxidant
action of the pomegranate. Indeed, in our study, a qualitative
phytochemical screening of the crude extract revealed the
presence of antioxidants substances, i.e., tannins and flavonoids.
The most important finding in this study was the capacity of
treatment with PHE in improving coronary vascular reactivity.
We believe that the increased endothelium-dependent relaxation
and the reduction in the level of O•−2 in the Sham-PHE
group suggest that the treatment reduces ROS concentration
and increases NO bioavailability. We also investigated whether
the treatment with PHE was able to alter the expression of
antioxidant enzymes such as SOD-2 and catalase. Interestingly,
our data showed that after the treatment, there was a significant
increase in the SOD-2 expression in the OVX-PHE group,
enzyme that promotes O•−2 dismutation, which is formed in
greater amounts in hypertension (Androwiki et al., 2015).
Our results corroborate data from the literature showing
the relationship between pomegranate and antioxidant system
activity, in which polyphenois promoted upregulation in SOD
in hypertensive rats (Bagri et al., 2009; Althunibat et al., 2010;
Mohan et al., 2010).
Our results corroborate Ignarro et al. (2006) that showed
that the treatment with pomegranate promotes an increase
in the biological actions of NO by antioxidant effects of
polyphenols and not only through changes in transcriptional
expression or catalytic activity of eNOS. Therefore, we believe
that the treatment with PHE prevented the reduction of NO
bioavailability induced by castration through: (i) its antioxidant
action and (ii) increase in the SOD-2 expression. These
actions in conjunction with the increase in the generation of
plasma nitrite levels could explain the results found in this
study.
Phytoestrogens have a function similar to estrogen, such as
hypocholesterolemic effects, that could reduce the risk of CVDs
associated with menopause (Lissin and Cooke, 2000; Gencel
et al., 2012). As expected, we observed an improvement in lipid
profile in both treated groups. Indeed, other studies showed
that pomegranate extract (PHE) improves atherogenic markers
(Neyrinck et al., 2013). These results were also observed in clinical
studies, where the consumption of concentrated pomegranate
juice improved lipid profile (Esmaillzadeh et al., 2004). Fuhrman
et al. (2010) demonstrated that the polyphenols in pomegranate
can increase levels of the enzyme HDL-associated PON-1 and
reduced LDL-associated PON-1. The PON-1, also known as
aromatic esterase 1, is responsible for protecting HDL and LDL
of lipid oxidation.
CONCLUSION
We demonstrated that the use of PHE has beneficial effects
contributing to: (i) reduction in SBP; (ii) increase in the
endothelium-dependent relaxation in coronary arteries;
(iii) reduction in oxidative stress; (iv) inhibition of eNOS
phosphorylation at its inhibitory residue Thr495 and (v) improve
in lipid profile. Taken together, these effects can protect against
the development and/or progression of CVDs. Most of these
effects may be related, at least in part, with estrogenic actions
of phytoestrogens. These findings have important implications
for the prevention of CVDs, especially in coronary vascular bed
of the female with sex hormonal deficiency and hypertension.
Therefore, the characterization of PHE role may provide a
new approach to the development of new forms of therapeutic
intervention in the treatment of hypertension associated with
hormonal dysfunction.
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